WORLDSymposium gathers together clinicians and researchers from across the globe who are interested in exploring the latest discoveries and research related to lysosomal diseases.
Blueprint Genetics and ARCHIMEDlife have partnered to provide high quality biochemical and molecular testing for Rare Diseases in North America. We offer next generation sequencing tests for single genes, panel and clinical whole exome sequencing. This year, we are expanding these services by offering biochemical testing to better collaborate with clinicians, researchers and personalized health care companies to provide patients with a faster, earlier diagnoses.
Interested to learn more?
- Read our news: Blueprint Genetics and ARCHIMEDlife form a partnership to launch high quality biochemical testing for Rare
- Recent webinar: Common Myths About Genetic Testing
- Our offering: providing 29 panels for metabolic disorders including disorders of lysosomal storage
Our team looks forward to meeting you at booth #208!
Ariana Lichtenstein, Juha Koskenvuo, MD, PhD, Sean McEvoy, Samuel Myllykangas, PhD, and Solveig Sjöblom, PhD